Firefly Neuroscience, Inc. (AIFF)

NASDAQ: AIFF · Real-Time Price · USD

4.110

+0.020 (0.49%)

At close: Mar 28, 2025, 4:00 PM

4.095

-0.015 (-0.37%)

After-hours: Mar 28, 2025, 7:50 PM EDT

Firefly Neuroscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.07	0.5	-	0.03
Gross Profit	0.07	0.5	-	0.03
Selling, General & Admin	6.71	2.84	2.07	1.76
Research & Development	1.55	0.74	1.3	2.93
Operating Expenses	8.26	3.58	3.37	4.69
Operating Income	-8.19	-3.08	-3.37	-4.65
Interest Expense	-0.04	-0.02	-0.44	-0.14
Currency Exchange Gain (Loss)	0.04	0.04	-0.13	-
Other Non Operating Income (Expenses)	0.44	0.46	0.01	-0
EBT Excluding Unusual Items	-7.75	-2.6	-3.93	-4.79
Gain (Loss) on Sale of Investments	-	-	-	0.55
Gain (Loss) on Sale of Assets	-	-	0.17	0.31
Asset Writedown	-	-	-0.08	-
Other Unusual Items	-	-	-0.06	-0.45
Pretax Income	-7.75	-2.6	-3.9	-4.38
Income Tax Expense	0	0	-	-
Net Income	-7.75	-2.6	-3.9	-4.38
Net Income to Common	-7.75	-2.6	-3.9	-4.38
Shares Outstanding (Basic)	33	31	1	-
Shares Outstanding (Diluted)	33	31	1	-
Shares Change (YoY)	1022.20%	2152.75%	-	-
EPS (Basic)	-0.23	-0.08	-2.83	-
EPS (Diluted)	-0.23	-0.08	-2.83	-
Gross Margin	100.00%	100.00%	-	100.00%
Operating Margin	-11060.81%	-618.07%	-	-14543.75%
Profit Margin	-10475.68%	-522.69%	-	-13690.63%
EBITDA	-8.17	-3.06	-3.35	-4.23
D&A For EBITDA	0.01	0.01	0.01	0.43
EBIT	-8.19	-3.08	-3.37	-4.65

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q